{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:28:55Z","timestamp":1790706535925,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T18:14:49Z","timestamp":1550254489000},"page":"1565-1576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cyclophosphamide enhances the release of tumor exosomes that elicit a specific immune response in vivo in a murine T-cell lymphoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Federico","family":"Cocozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Menay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Tsacalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda","family":"Elisei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pura","family":"Sampedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Waldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Gravisaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mongini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.004_b0005","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1098\/rstb.2016.0479","article-title":"Why the need and how to approach the functional diversity of extracellular vesicles","volume":"373","author":"Tkach","year":"2018","journal-title":"Phil Trans R Soc B"},{"key":"10.1016\/j.vaccine.2019.02.004_b0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"EL Andaloussi","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2019.02.004_b0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0183915","article-title":"New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes","volume":"12","author":"Fernando","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.02.004_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00203","article-title":"Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications","volume":"6","author":"De Toro","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","article-title":"Malignant effusions and immunogenic tumour-derived exosomes","volume":"360","author":"Andre","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.02.004_b0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bcmd.2005.06.008","article-title":"Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial","volume":"35","author":"Navabi","year":"2005","journal-title":"Blood Cells, Mol Dis"},{"key":"10.1016\/j.vaccine.2019.02.004_b0040","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0002-9440(10)63739-X","article-title":"Proteomic analysis of exosomes secreted by human mesothelioma cells","volume":"164","author":"Hegmans","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.00286","article-title":"Exosomes isolated from ascites of T-cell lymphoma-bearing mice expressing surface CD24 and HSP-90 induce a tumor-specific immune response","volume":"8","author":"Menay","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/85438","article-title":"Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming","volume":"7","author":"Wolfers","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.02.004_b0055","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1158\/1078-0432.CCR-05-0810","article-title":"More efficient induction of HLA-A[ast]0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells","volume":"11","author":"Dai","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2019.02.004_b0060","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1158\/0008-5472.CAN-06-3456","article-title":"Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2","volume":"67","author":"Clayton","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2019.02.004_b0065","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/0008-5472.CAN-07-3163","article-title":"Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses","volume":"68","author":"Zeelenberg","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2019.02.004_b0070","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood-2004-03-0824","article-title":"Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells","volume":"104","author":"Morelli","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2019.02.004_b0075","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/eji.200535501","article-title":"Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells","volume":"36","author":"Chen","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0080","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/ijc.24479","article-title":"Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors","volume":"125","author":"Wysoczynski","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2019.02.004_b0085","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1089\/scd.2012.0095","article-title":"Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo","volume":"21","author":"Zhang","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.vaccine.2019.02.004_b0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2407-12-421","article-title":"Hypoxic enhancement of exosome release by breast cancer cells","volume":"12","author":"King","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.vaccine.2019.02.004_b0095","doi-asserted-by":"crossref","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","article-title":"Microenvironmental pH is a key factor for exosome traffic in tumor cells","volume":"284","author":"Parolini","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2019.02.004_b0100","doi-asserted-by":"crossref","first-page":"15874","DOI":"10.1074\/jbc.M112.340588","article-title":"Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro","volume":"287","author":"Lv","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2019.02.004_b0105","article-title":"Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells","author":"Samuel","year":"2017","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"10.1016\/j.vaccine.2019.02.004_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18051007","article-title":"Chloramidine\/bisindolylmaleimide-I-mediated inhibition of exosome and microvesicle release and enhanced efficacy of cancer chemotherapy","volume":"18","author":"Kosgodage","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2019.02.004_b0115","first-page":"1","article-title":"Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior","author":"Bandari","year":"2017","journal-title":"Matrix Biol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/bjc.2017.18","article-title":"Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK","volume":"116","author":"Patel","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2019.02.004_b0125","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.182.3.1449","article-title":"Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway","volume":"182","author":"Chen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015353","article-title":"Exosomes communicate protective messages during oxidative stress; Possible role of exosomal shuttle RNA","author":"Eldh","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.02.004_b0135","doi-asserted-by":"crossref","first-page":"e16899","DOI":"10.1371\/journal.pone.0016899","article-title":"Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia\/lymphoma T and B cells","volume":"6","author":"Hedlund","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.02.004_b0140","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.1002991","article-title":"Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine","volume":"186","author":"Chen","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0145","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/02656736.2015.1036384","article-title":"Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress","volume":"31","author":"Yang","year":"2015","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.vaccine.2019.02.004_b0150","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","article-title":"Clinical pharmacokientics of cyclophosphamide","volume":"44","author":"De Jonge","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.vaccine.2019.02.004_b0155","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2019.02.004_b0160","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/1078-0432.CCR-06-1209","article-title":"Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration","volume":"13","author":"Bracci","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"342","key":"10.1016\/j.vaccine.2019.02.004_b0165","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"80","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.02.004_b0170","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2019.02.004_b0175","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-03-3126","article-title":"Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression","volume":"64","author":"Hamano","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2019.02.004_b0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1290\/1071-2690(2001)037<0499:COTIAT>2.0.CO;2","article-title":"Characterization of the immunophenotype and the metastatic properties of a murine T-lymphoma cell line. Unexpected expression of cytoplasmatic CD4","volume":"37","author":"Mongini","year":"2001","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.vaccine.2019.02.004_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants","author":"Th\u00e9ry","year":"2006","journal-title":"Curr Protoc Cell Biol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-1759(00)00321-5","article-title":"Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry","volume":"247","author":"Clayton","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2019.02.004_b0195","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.intimp.2005.04.016","article-title":"Transgene expression enhancement in T-lymphoma cell lines","volume":"5","author":"Ruybal","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0200","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/nprot.2006.268","article-title":"Intracellular cytokine optimization and standard operating procedure","volume":"1","author":"Lamoreaux","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2019.02.004_b0205","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/nprot.2007.296","article-title":"Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester","volume":"2","author":"Quah","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2019.02.004_b0210","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/cyto.a.20887","article-title":"Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis","volume":"77","author":"Cao","year":"2010","journal-title":"Cytom Part A"},{"key":"10.1016\/j.vaccine.2019.02.004_b0215","doi-asserted-by":"crossref","first-page":"214074","DOI":"10.1155\/2010\/214074","article-title":"Cellular stress responses: cell survival and cell death","volume":"2010","author":"Fulda","year":"2010","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0220","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis secretion and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.leu.2404959","article-title":"Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo","volume":"22","author":"Wang","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.vaccine.2019.02.004_b0230","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1073\/pnas.1220998110","article-title":"Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development","volume":"110","author":"Kucharzewska","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.02.004_b0235","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4161\/cib.3.5.12474","article-title":"Exosomal membrane molecules are potent immune response modulators","volume":"3","author":"Anand","year":"2010","journal-title":"Commun Integr Biol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0240","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.4049\/jimmunol.180.6.4299","article-title":"Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages","volume":"180","author":"Vega","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0245","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.02.004_b0250","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.02.004_b0255","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bcmd.2005.03.003","article-title":"Exosomes and the MICA-NKG2D system in cancer","volume":"34","author":"Clayton","year":"2005","journal-title":"Blood Cells, Mol Dis"},{"key":"10.1016\/j.vaccine.2019.02.004_b0260","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1582-4934.2006.tb00406.x","article-title":"Prospects for exosomes in immunotherapy of cancer","volume":"10","author":"Mignot","year":"2006","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.vaccine.2019.02.004_b0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymthe.2005.09.015","article-title":"Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive","volume":"13","author":"Kim","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2019.02.004_b0270","first-page":"31","article-title":"Exosomes as novel therapeutic nanodevices","volume":"8","author":"Delcayre","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2019.02.004_b0275","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.cdd.4402237","article-title":"Tumour-released exosomes and their implications in cancer immunity","volume":"15","author":"Iero","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.vaccine.2019.02.004_b0280","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","article-title":"Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM","volume":"107","author":"Runz","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/annonc\/mdh918","article-title":"Exosomes for cancer immunotherapy","volume":"15","author":"Andre","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0290","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.4049\/jimmunol.172.4.2137","article-title":"Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection","volume":"172","author":"Chaput","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0295","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1189\/jlb.0206094","article-title":"Dendritic cell derived-exosomes: biology and clinical implementations","volume":"80","author":"Chaput","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0300","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1615\/CritRevImmunol.v25.i3.30","article-title":"Dendritic cell-derived exosomes as cell-free peptide-based vaccines","volume":"25","author":"Ta\u00efeb","year":"2005","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0305","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI81137","article-title":"Dendritic cell-derived exosomes for cancer therapy","volume":"126","author":"Pitt","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.02.004_b0310","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-1759(02)00330-7","article-title":"Production and characterization of clinical grade exosomes derived from dendritic cells","volume":"270","author":"Lamparski","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2019.02.004_b0315","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/mt.2008.1","article-title":"Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer","volume":"16","author":"Dai","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2019.02.004_b0320","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.15252\/embj.201696003","article-title":"Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes","volume":"36","author":"Tkach","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2019.02.004_b0325","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.02.004_b0330","doi-asserted-by":"crossref","first-page":"E968","DOI":"10.1073\/pnas.1521230113","article-title":"Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes","volume":"113","author":"Kowal","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.02.004_b0335","article-title":"Systematic review of factors influencing extracellular vesicle yield from cell cultures","author":"Gudbergsson","year":"2015","journal-title":"Cytotechnology"},{"key":"10.1016\/j.vaccine.2019.02.004_b0340","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","article-title":"Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8+CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70","volume":"14","author":"Xie","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.vaccine.2019.02.004_b0345","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","article-title":"Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells","volume":"65","author":"Gastpar","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2019.02.004_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010136","article-title":"Exosomal hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria","volume":"5","author":"Anand","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:57Z","timestamp":1759401057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19301872"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclophosphamide enhances the release of tumor exosomes that elicit a specific immune response in vivo in a murine T-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}